# Best Mitochondrial Peptides: SS-31, MOTS-c, and How People Stack Them
> Note: PeptIQ is not a medical provider. Mitochondrial peptide content is educational. Human evidence varies widely by compound and indication.
"SS31 dosage" and "mots c dosage" sit near the top of PeptIQ search queries. The mitochondrial stack page is also a top blog URL. This listicle is the short route into that cluster.
1. MOTS-c (search volume leader)
MOTS-c is a mitochondrial-derived peptide discussed for metabolic signaling and cellular stress responses. On PeptIQ it is the mitochondrial compound with the clearest dedicated dosing page.
Read: MOTS-c Dosing Guide: Recommended Dose Protocol
Add timing context: When to Take MOTS-c
Policy context (access is not the same as dosing): MOTS-c 503A Recommendation
2. SS-31 / elamipretide
SS-31 (elamipretide) is searched as "ss31" and "ss31 peptide dosage." It is often discussed for mitochondrial membrane interactions and cardiometabolic research framing. PeptIQ's strongest educational entry for SS-31 is the stack guide with MOTS-c, which covers how the two are compared and combined in community protocols.
Read: SS-31 + MOTS-c Mitochondrial Stack Guide
3. The SS-31 + MOTS-c stack
People rarely stop at one mitochondrial compound in forum stacks. The stack guide is the place to understand:
- Why the pair is popular
- How dosing discussions differ between the two
- What to track so you are not guessing which compound changed fatigue or training output
Read: SS-31 + MOTS-c Mitochondrial Stack Guide
4. MOTS-c next to GLP-1 / retatrutide protocols
Mitochondrial peptides often appear as "support" compounds beside incretin agonists. That creates attribution problems. If retatrutide is already suppressing appetite and changing training energy, adding MOTS-c without a log makes the stack story impossible to interpret.
Useful companions:
5. Research literacy pages
If you want mechanism and trial context rather than dose tables:
Quick ranking for search intent
| Intent | Open this |
|---|
| mots c dosage / mots-c dosage | MOTS-c dosing guide |
| ss31 dosage / ss31 peptide dosage | SS-31 + MOTS-c stack guide |
| Mitochondrial stack overview | Same stack guide |
| Timing (fasted vs training day) | MOTS-c timing guide |
| Access / compounding news | MOTS-c 503A recommendation |
| Beside retatrutide | Tesamorelin + MOTS-c + retatrutide stack |
Practical rules before you open five tabs
- Dose literacy before stack literacy. Learn MOTS-c alone or SS-31 framing alone before combining.
- Track energy, HRV or resting heart rate, training volume, and sleep. Mitochondrial claims are easy to feel and hard to measure. Pick two metrics and stick with them for 4 weeks.
- Do not change retatrutide dose and MOTS-c dose in the same week if you care about attribution.
- Keep reconstitution separate. Mitochondrial peptides still need correct concentration math. Use the reconstitution calculator when vial sizes change.
Frequently Asked Questions
Q: Is SS-31 the same as elamipretide?
A: Yes. Elamipretide is the common clinical name; SS-31 is the research nickname that dominates search.
Q: Which mitochondrial peptide has the better human evidence story?
A: It depends on the endpoint. Read the dosing and research pages rather than treating social rankings as evidence grades. MOTS-c has more PeptIQ educational depth on dosing and timing; SS-31 discussions often live inside cardiometabolic and stack contexts.
Q: Can I start with the stack guide only?
A: You can skim it for orientation, then return to the MOTS-c dosing guide for the dose-table detail searchers actually want.
Q: Where does NAD+ fit?
A: NAD+ is adjacent, not identical. See Should You Cycle NAD+ and the NAD+ 1000 mg reconstitution guide after the mitochondrial peptide basics.
Bottom line
For mitochondrial peptide search on PeptIQ, the winning path is MOTS-c dosing → SS-31 + MOTS-c stack → timing and retatrutide-adjacent pages only if those are your actual questions. That matches both the query list and the top-page data.
